Optimización de la función intestinal en pacientes con fibrosis quística mediante la administración de probióticos

Pina, D. Infante; Ferreiro, Susana; Vernetta, Alba Torrent; Segarra, Óscar; Smith, Mark M.; Tizziano, L. Gartner; Albert, É.

doi:10.1016/s1695-4033(08)75231-7

Cited by 27 publications

(7 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We also did not find articles regarding prebiotic use in cystic fibrosis. Selection by title and summary identified 40 studies for full reading, and 1 study was discarded due to poor methodological quality assessed by the Downs & Black criteria (data not shown) (15). Only 10 studies met the criteria for inclusion in the systematic review.…”

Section: Resultsmentioning

confidence: 99%

Systematic Review of Probiotics for Cystic Fibrosis Patients

Neri¹,

Taminato

Filho

2019

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

Background: Cystic fibrosis (CF) is associated with chronic respiratory disease and pancreatic insufficiency and results in the malabsorption of nutrients and intestinal inflammation. There is evidence that probiotic supplementation may impact the gastrointestinal and respiratory microbiota. This study aimed to categorize current evidence regarding the effects of supplementing with probiotics in CF patients on gastrointestinal and respiratory outcomes according to the type of intervention. Methods: The initial database search included all identified studies according to the recommendations of the Cochrane Collaboration, regardless of language, publication date or design. Studies were categorized by probiotic strain (Lactobacillus reuteri; Lactobacillus rhamnosus GG or a mix of strains); dosage (low dosage if <109 CFU [colony forming units] or high dosage if >109 CFU); and duration of intervention (1, 3, 6, or 12 months). Assessment of quality was performed based on the Cochrane risk of bias criteria and the Downs & Black checklist. Results: A total of 205 studies were identified; however, only 9 met the criteria for inclusion. The studies were considered to have a high risk of bias, hampering the possibility of performing a meta-analysis. Eighty percent of the studies (4 of 5) reported a positive result for intestinal inflammation, and another 4 studies (4 of 5) reported a positive result for pulmonary exacerbation frequency, regardless of the treatment approach. Conclusions: The present data indicate a promising future for probiotic use in cystic fibrosis, which has an impact on exacerbations and intestinal inflammation; however, further studies of standardized therapeutic interventions are required.

show abstract

Section: Resultsmentioning

confidence: 99%

Systematic Review of Probiotics for Cystic Fibrosis Patients

Neri¹,

Taminato

Filho

2019

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

“…Intestinal inflammation is another typical finding in patients with CF and gut bacterial overgrowth may be present (4–6). Bruzzese et al reported that fecal calprotectin and rectal nitric oxide are increased in virtually all children with CF, suggesting that the intestine is a target organ in CF and is in a constant inflammatory state (5).…”

mentioning

confidence: 99%

Lactobacillus reuteri ATCC55730 in Cystic Fibrosis

Nardo

Oliva

Menichella³

et al. 2014

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

“…Results reported improvement in abdominal comfort (81%), reduction in number of stools (56%) and stool fat and sugar. Probiotics lead to improvement in both clinical and biochemical gastral function in CF patients 33 . Probiotic diminish fecal calprotectin (abdominal inflammation marker) due to CF.…”

Section: The Effect Of Probiotics On Different Diseases Cystic Fibrosis Diseasementioning

confidence: 99%

The Effect of Probiotics on Various Diseases and their Therapeutic Role: An Update Review

Hashempour‐Baltork¹,

M.J.Sheikh²,

Eskandarzadeh³

et al. 2021

J. Pure Appl. Microbiol.

View full text Add to dashboard Cite

Probiotic bacteria play a critical and functional role in clinical and nutritional applications. In the present study, the ability of various probiotics and their metabolites in the prevention and treatment of different diseases, infections and disorders was reviewed. The issues that were noticed are included: Fibrocystic, diabetes, acne, colon cancer, cardiovascular, urinary tract infections, atopic eczema syndrome, food allergies and obesity. Enhancement in using drug treatment has led to the appearance of drug-resistance concern, thus probiotics can be a suitable choice. This review focuses on the effect of probiotic bacteria and their metabolites on immune-boosting, prevention and treatment of these diseases. For this purpose, after a short glance at each disease, infection and disorder, the mechanism of probiotic action and recent studies about that disease are reviewed. It could be recommended that probiotics consumption, perhaps from birth to all stages of life, would be effective in the life-long, development of health effects and disease treatments.

show abstract

Optimización de la función intestinal en pacientes con fibrosis quística mediante la administración de probióticos

Cited by 27 publications

References 25 publications

Systematic Review of Probiotics for Cystic Fibrosis Patients

Systematic Review of Probiotics for Cystic Fibrosis Patients

Lactobacillus reuteri ATCC55730 in Cystic Fibrosis

The Effect of Probiotics on Various Diseases and their Therapeutic Role: An Update Review

Contact Info

Product

Resources

About